Related Experiment Video
Updated: Jun 21, 2026
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
Nanomaterials-Induced PANoptosis: A Promising Anti-Tumor Strategy
Guanghui Hou1, Youdong Chen1, Huali Lei1
1Institute of Functional Nano & Soft Materials (FUNSOM) Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, 215123, China.
Angewandte Chemie (International Ed. in English)
|November 19, 2024
Summary
Harnessing PANoptosis, a novel cell death pathway, offers a potent strategy against cancer. Nanomaterials show promise in enhancing PANoptosis-based cancer therapies by overcoming current treatment limitations.
Area of Science:
- Oncology
- Cell Death Research
- Nanomedicine
Background:
- Malignant tumors represent a major global health challenge.
- Targeting programmed cell death pathways is a key cancer treatment strategy.
- PANoptosis, a novel regulated cell death, synergistically combines pyroptosis, apoptosis, and necroptosis.
Purpose of the Study:
- To review the concept and mechanisms of PANoptosis.
- To highlight nanoagent applications in PANoptosis-based anti-cancer therapy.
- To discuss challenges and future directions for clinical translation of PANoptosis therapies.
Main Methods:
- Comprehensive literature review on PANoptosis and nanoagent applications.
- Analysis of current limitations in small molecule and cytokine-based PANoptosis inducers.
- Exploration of nanomaterial properties for optimizing PANoptosis induction.
Main Results:
- PANoptosis effectively inhibits cancer cell growth and resistance.
- Induction of PANoptosis activates a robust anti-tumor immune response.
- Nanomaterials offer unique advantages for metabolic stability and tumor specificity in PANoptosis induction.
Conclusions:
- Tumor-specific induction of PANoptosis is a promising cancer therapeutic strategy.
- Nanomaterials represent a significant advancement for optimizing PANoptosis-based cancer treatments.
- Further research is needed for the clinical translation of these novel therapeutic approaches.
